In the last 12 months, insiders at GRI Bio, Inc. ($GRI) filed 33 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
GRI Bio, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Szekeres David Leslie (Director) — 5 transactions totaling $4
- Rongen Roelof (Director) — 5 transactions totaling $4
- SIMPSON CAMILLA V (Director) — 5 transactions totaling $4
- Baker David Charles (Director) — 5 transactions totaling $4
- Kelly Leanne (Chief Financial Officer) — 4 transactions totaling $2
View all SEC Filings for GRI Bio, Inc. (GRI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 18, 2025 | Kelly Leanne | Chief Financial Officer | A | Stock Option (Right to Buy) | 43222 | $0.00 | 43,222.0000 | 2,496,800 | 9999.99% | 1.73% |
| Sept. 18, 2025 | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 39897 | $0.00 | 39,897.0000 | 2,496,800 | 9999.99% | 1.60% |
| Sept. 18, 2025 | Baker David Charles | Director | A | Stock Option (Right to Buy) | 23605 | $0.00 | 23,605.0000 | 2,496,800 | 9999.99% | 0.95% |
| Sept. 18, 2025 | SIMPSON CAMILLA V | Director | A | Stock Option (Right to Buy) | 23605 | $0.00 | 23,605.0000 | 2,496,800 | 9999.99% | 0.95% |
| Sept. 18, 2025 | Chaturvedi Vipin | Chief Scientific Officer | A | Stock Option (Right to Buy) | 43222 | $0.00 | 43,222.0000 | 2,496,800 | 9999.99% | 1.73% |
| Sept. 18, 2025 | Rongen Roelof | Director | A | Stock Option (Right to Buy) | 23605 | $0.00 | 23,605.0000 | 2,496,800 | 9999.99% | 0.95% |
| Sept. 18, 2025 | Hertz Walter Marc | Chief Executive Officer | A | Stock Option (Right to Buy) | 103067 | $0.00 | 103,067.0000 | 2,496,800 | 9999.99% | 4.13% |
| Aug. 26, 2025 | Kelly Leanne | Chief Financial Officer | A | Stock Option (Right to Buy) | 11854 | $0.00 | 11,854.0000 | 2,496,800 | 9999.99% | 0.47% |
| Aug. 26, 2025 | Baker David Charles | Director | A | Stock Option (Right to Buy) | 5994 | $0.00 | 5,994.0000 | 2,496,800 | 9999.99% | 0.24% |
| Aug. 26, 2025 | Rongen Roelof | Director | A | Stock Option (Right to Buy) | 5994 | $0.00 | 5,994.0000 | 2,496,800 | 9999.99% | 0.24% |
| Aug. 26, 2025 | Chaturvedi Vipin | Chief Scientific Officer | A | Stock Option (Right to Buy) | 11854 | $0.00 | 11,854.0000 | 2,496,800 | 9999.99% | 0.47% |
| Aug. 26, 2025 | SIMPSON CAMILLA V | Director | A | Stock Option (Right to Buy) | 5994 | $0.00 | 5,994.0000 | 2,496,800 | 9999.99% | 0.24% |
| Aug. 26, 2025 | Hertz Walter Marc | Chief Executive Officer | A | Stock Option (Right to Buy) | 26688 | $0.00 | 26,688.0000 | 2,496,800 | 9999.99% | 1.07% |
| Aug. 26, 2025 | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 10276 | $0.00 | 10,276.0000 | 2,496,800 | 9999.99% | 0.41% |
| Aug. 13, 2025 | Baker David Charles | Director | A | Stock Option (Right to Buy) | 4527 | $0.00 | 4,527.0000 | 2,496,800 | 9999.99% | 0.18% |
| Aug. 13, 2025 | Rongen Roelof | Director | A | Stock Option (Right to Buy) | 4527 | $0.00 | 4,527.0000 | 2,496,800 | 9999.99% | 0.18% |
| Aug. 13, 2025 | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 7545 | $0.00 | 7,545.0000 | 2,496,800 | 9999.99% | 0.30% |
| Aug. 13, 2025 | SIMPSON CAMILLA V | Director | A | Stock Option (Right to Buy) | 4527 | $0.00 | 4,527.0000 | 2,496,800 | 9999.99% | 0.18% |
| Jan. 23, 2025 | SIMPSON CAMILLA V | Director | A | Stock Option (Right to Buy) | 30297 | $0.69 | 30,297.0000 | 525,485 | 9999.99% | 5.77% |
| Jan. 23, 2025 | Chaturvedi Vipin | Chief Scientific Officer | A | Stock Option (Right to Buy) | 43319 | $0.69 | 43,319.0000 | 525,485 | 9999.99% | 8.24% |
| Jan. 23, 2025 | Hertz Walter Marc | Chief Executive Officer | A | Stock Option (Right to Buy) | 129730 | $0.69 | 129,730.0000 | 525,485 | 9999.99% | 24.69% |
| Jan. 23, 2025 | Kelly Leanne | Chief Financial Officer | A | Stock Option (Right to Buy) | 43319 | $0.69 | 43,319.0000 | 525,485 | 9999.99% | 8.24% |
| Jan. 23, 2025 | Baker David Charles | Director | A | Stock Option (Right to Buy) | 30297 | $0.69 | 30,297.0000 | 525,485 | 9999.99% | 5.77% |
| Jan. 23, 2025 | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 51937 | $0.69 | 51,937.0000 | 525,485 | 9999.99% | 9.88% |
| Jan. 23, 2025 | Rongen Roelof | Director | A | Stock Option (Right to Buy) | 30297 | $0.69 | 30,297.0000 | 525,485 | 9999.99% | 5.77% |
| Sept. 22, 2023 | Kelly Leanne | Chief Financial Officer | A | Stock Option (Right to Buy) | 83333 | $1.52 | 83,333.0000 | 646 | 9999.99% | 100.00% |
| Aug. 10, 2023 | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 34483 | $2.90 | 34,483.0000 | 646 | 9999.99% | 100.00% |
| Aug. 10, 2023 | SIMPSON CAMILLA V | Director | A | Stock Option (Right to Buy) | 34483 | $2.90 | 34,483.0000 | 646 | 9999.99% | 100.00% |
| Aug. 10, 2023 | Rongen Roelof | Director | A | Stock Option (Right to Buy) | 34483 | $2.90 | 34,483.0000 | 646 | 9999.99% | 100.00% |
| Aug. 10, 2023 | Baker David Charles | Director | A | Stock Option (Right to Buy) | 34483 | $2.90 | 34,483.0000 | 646 | 9999.99% | 100.00% |
| April 21, 2023 | Hertz Walter Marc | Chief Executive Officer | A | Common Stock | 385510 | $0.00 | 385,510.0000 | 646 | 9999.99% | 100.00% |
| April 21, 2023 | Agro Albert | Chief Medical Officer | A | Common Stock | 172189 | $0.00 | 172,189.0000 | 646 | 9999.99% | 100.00% |
| April 21, 2023 | Chaturvedi Vipin | Chief Scientific Officer | A | Common Stock | 172189 | $0.00 | 172,189.0000 | 646 | 9999.99% | 100.00% |